These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1082 related articles for article (PubMed ID: 23534055)

  • 41. Ketamine disrupts neuromodulatory control of glutamatergic synaptic transmission.
    Lur G; Fariborzi M; Higley MJ
    PLoS One; 2019; 14(3):e0213721. PubMed ID: 30865708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.
    Miller OH; Yang L; Wang CC; Hargroder EA; Zhang Y; Delpire E; Hall BJ
    Elife; 2014 Oct; 3():e03581. PubMed ID: 25340958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade.
    Nosyreva E; Autry AE; Kavalali ET; Monteggia LM
    Front Mol Neurosci; 2014; 7():94. PubMed ID: 25520615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
    Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug.
    Pałucha-Poniewiera A
    Pharmacol Rep; 2018 Oct; 70(5):837-846. PubMed ID: 30086517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of synaptic plasticity by stress and antidepressants.
    Popoli M; Gennarelli M; Racagni G
    Bipolar Disord; 2002 Jun; 4(3):166-82. PubMed ID: 12180272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Resolvins as novel targets for rapid-acting antidepressants].
    Deyama S
    Nihon Yakurigaku Zasshi; 2020; 155(6):381-385. PubMed ID: 33132254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression.
    Wang J; Jing L; Toledo-Salas JC; Xu L
    Neurosci Bull; 2015 Feb; 31(1):75-86. PubMed ID: 25488282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.
    Ficek J; Zygmunt M; Piechota M; Hoinkis D; Rodriguez Parkitna J; Przewlocki R; Korostynski M
    BMC Genomics; 2016 May; 17():362. PubMed ID: 27188165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response.
    Derosa S; Misztak P; Mingardi J; Mazzini G; Müller HK; Musazzi L
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110871. PubMed ID: 37793481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
    Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
    Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
    Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
    Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression.
    Drewniany E; Han J; Hancock C; Jones RL; Lim J; Nemat Gorgani N; Sperry JK; Yu HJ; Raffa RB
    J Clin Pharm Ther; 2015 Apr; 40(2):125-30. PubMed ID: 25545040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.
    Jett JD; Boley AM; Girotti M; Shah A; Lodge DJ; Morilak DA
    Psychopharmacology (Berl); 2015 Sep; 232(17):3123-33. PubMed ID: 25986748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
    Li N; Lee B; Liu RJ; Banasr M; Dwyer JM; Iwata M; Li XY; Aghajanian G; Duman RS
    Science; 2010 Aug; 329(5994):959-64. PubMed ID: 20724638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine.
    Cadeddu R; Jadzic D; Carboni E
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1678-82. PubMed ID: 27569123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ketamine's antidepressant action: beyond NMDA receptor inhibition.
    Hashimoto K
    Expert Opin Ther Targets; 2016 Nov; 20(11):1389-1392. PubMed ID: 27646666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
    Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC
    J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A review of rodent models.
    Acero-Castillo MC; Correia MBM; Caixeta FV; Motta V; Barros M; Maior RS
    Neuropharmacology; 2024 Nov; 258():110088. PubMed ID: 39032814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.